Cancer Institute– A national cancer institute
designated cancer center

Joel Killen

Back to Profile

Publication Details

  • Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.

    Killen JD, Fortmann SP, Murphy GM, Hayward C, Fong D, Lowenthal K, Bryson SW, Killen DT, Schatzberg AF. Addiction. 2010; 105 (9): 1660-8

    To examine the effectiveness of transdermal selegiline for producing cigarette smoking abstinence.

    PubMedID: 20707784

Stanford Medicine Resources:

Footer Links: